Search

Luis Diaz Jr., MD, Head of the Division of Solid Tumor Oncology, and incumbent of the Grayer Family Chair, and Kojo S.J. Elenitoba-Johnson, MD, Chair of the Department of Pathology and Laboratory Medicine, Member in the Human Oncology Pathogenesis Program (HOPP), and the incumbent of the James Ewing Alumni Chair of Pathology at Memorial Sloan Kettering Cancer Center (MSK), have been elected to the National Academy of Medicine (NAM), one of the highest honors bestowed upon scientists worldwide.

… Tuesday, October 10, 2023 Luis Diaz Jr., MD , Head of the Division of Solid Tumor Oncology, and incumbent of the Grayer Family Chair, and  Kojo S.J. Elenitoba-Johnson, MD , Chair of the Department of Pathology and Laboratory Medicine, Member in the Human Oncology Pathogenesis Program (HOPP), and the

New findings from researchers at the Sloan Kettering Institute suggest that cancer causes may be lurking in the molecule that bridges DNA and protein.

… Monday, August 27, 2018 Summary Researchers at the Sloan Kettering Institute have found that changes in an information-carrying molecule called messenger RNA can inactivate tumor-suppressing proteins and thereby promote cancer. The findings pinpoint previously unknown drivers of the disease. IMPORTANT

New research led by investigators at Memorial Sloan Kettering Cancer Center identifies three genes that specifically mediate the metastasis, or spread, of breast cancer to the brain and illuminates the mechanisms by which this spread occurs.

… Wednesday, May 6, 2009 New research led by investigators at Memorial Sloan Kettering Cancer Center (MSKCC) identifies three genes that specifically mediate the metastasis, or spread, of breast cancer to the brain and illuminates the mechanisms by which this spread occurs. The study was published online

Meet Carmen Mendez, a perioperative nurse liaison at Memorial Sloan Kettering Cancer Center who is driven by compassion and empathy for the family members of patients undergoing surgery.

… Thursday, September 30, 2021 Carmen Mendez’s professional life began out of love for her mother. Love was the driving force behind her decision to go to nursing school. Now, as perioperative nurse liaison for the Josie Robertson Surgery Center , she is driven by compassion and empathy for the family

Learn how to eat right and stay at a healthy weight by following these tips from MSK experts on diet and nutrition.

… Friday, June 26, 2015 Summary Cancer and its treatments can affect your eating habits — and your weight. Since weight gain or loss can affect your prognosis or your chance of recovery, it’s important to be mindful of what you eat during and after treatment. Don’t restrict your diet, make sure you take

Learn about some lesser-known side effects from cancer treatment including falling caused by peripheral neuropathy, fatigue, hormone and sexual changes, and short-term memory problems (chemo brain).

… Tuesday, December 19, 2017 Even people who’ve had no experience with cancer have some idea of the side effects it can cause. Hair and weight changes , nausea , and other issues are common and can impact a person’s quality of life. But there are less-known complications that can have equally important

New MSK research identifies a promising immunotherapy target for acute myeloid leukemia; decodes genetic differences in tumors from patients with African ancestry; and finds a virtual mind-body fitness program reduced hospitalizations for those in active cancer treatment. A clinical trial led by MSK also resulted in the approval of a new combination therapy for non-small cell lung cancer.

… Tuesday, October 31, 2023 New research from Memorial Sloan Kettering Cancer Center (MSK) identifies a promising immunotherapy target for acute myeloid leukemia; decodes genetic differences in tumors from patients with African ancestry; and finds a virtual mind-body fitness program reduced hospitalizations

New MSK research develops a powerful new resource for studying gene regulation across eukaryotes; uncovers how “jumping genes” can drive cancer growth; describes how an unexpected oxygen sensor regulates ferroptosis; establishes a technique to map chromatin architecture in 3D; creates new models for studying schizophrenia-associated defects; and finds transcription factor 19 is critical for the responses of natural killer cells to viral infection.

… Friday, August 8, 2025 New research from Memorial Sloan Kettering Cancer Center (MSK) develops a powerful new resource for studying gene regulation across eukaryotes; uncovers how “jumping genes” can drive cancer growth; describes how an unexpected oxygen sensor regulates ferroptosis; establishes a technique

The adoptive cell therapy afamitresgene autoleucel (afami-cel) demonstrated a favorable response and duration of response in select patients with metastatic synovial sarcoma, according to results from an international phase 2 clinical trial published recently in The Lancet. 

… Thursday, March 28, 2024 UPDATE August 2, 2024: The U.S. Food and Drug Administration (FDA) has  granted accelerated approval  for the immunotherapy afamitresgene autoleucel for the treatment of adults with  synovial sarcoma . The adoptive cell therapy afamitresgene autoleucel (afami-cel) demonstrated

One’s big, one’s small. Somehow, they make it work.

… Wednesday, May 27, 2020 Summary A team of scientists at the Sloan Kettering Institute has discovered how the X and Y chromosomes find one another, break, and recombine during meiosis even though they have little in common. As chromosomes go, X and Y make an unlikely pair. The X is large and contains